Investor Resources

Maven Biotechnologies is presently undergoing an exciting phase of rapid growth. Strategic partners for commercialization have been engaged, product testing is underway. 
A Research Use Only System with a 'lab-on-a-credit-card', assay panels for autoimmune and infectious biomarkers, and a compact reader will be AVAILABLE at the end of Q4 2017.


For information about investment opportunities, please write to